Yet another report’s pointing out biotech’s bullish venture appeal – and how medical device investment continues to flag.
In fact, biotechnology funding for human therapeutics is so strong that its venture funding outpaces pharmaceuticals sevenfold, a PricewaterhouseCoopers venture analysis of the first quarter of 2015 life sciences sector found.
{iframe}http://medcitynews.com/2015/05/pwc-biotech-medtech-venture-capital/{/iframe}